Cutler Group LP T2 Biosystems, Inc. Call Options Transaction History

Cutler Group LP

8 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2022 Apr 14, 2022	SELL	$0.36 - $0.57 $252 - $398	-700 Reduced 33.33%	1,400 $0
Q4 2021 Jan 18, 2022	SELL	$0.46 - $0.94 $92 - $188	-200 Reduced 8.7%	2,100 $0
Q3 2021 Oct 26, 2021	SELL	$0.86 - $1.21 $5,418 - $7,623	-6,300 Reduced 73.26%	2,300 $0
Q2 2021 Jul 19, 2021	SELL	$1.04 - $1.69 $6,968 - $11,323	-6,700 Reduced 43.79%	8,600 $1,000
Q1 2021 Apr 26, 2021	BUY	$1.32 - $3.79 $19,404 - $55,713	14,700 Added 2450.0%	15,300 $3,000
Q4 2020 Jan 21, 2021	SELL	$1.06 - $1.51 $1,378 - $1,963	-1,300 Reduced 68.42%	600 $0
Q2 2018 Aug 10, 2018	BUY	$5.97 - $9.58 $10,149 - $16,286	1,700 Added 850.0%	1,900 $1,000
Q1 2018 May 11, 2018	BUY	$4.21 - $7.0 $842 - $1,400	200 New	200 $0

Ticker TTOO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 7,050,850
Market Cap $3.38M
Description
T2 Biosystems, Inc., an in vitro diagnostics company, develops diagnostic products and product candidates in the United States and internationally. Its technology enables detection of pathogens, biomarkers, and other abnormalities in various unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum, cerebral spinal fl...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.